Since 1980, advanced lung carcinomas were treated with palliative laser therapy for the purpose of opening the endobronchial stenosis and obstruction by either photodynamic therapy (PDT) (79 of 108) of Nd-YAG laser-treated patients. With a mortality rate of 0%, the greatest advantage of PDT over Nd-YAG treatment was safety. Considering complications, PDT seems to be useful for obstruction of lobar and segmental bronchus. Nevertheless, when deciding among alternative therapies, physicians treating patients with advanced lung carcinoma should give careful consideration to the benefit and complications of both laser therapies and decide the most suitable modality.
INTRODUCTION
Endoscopic surgery using laser is recognized as an effective modality for endobronchial carcinoma. Recently, however, attention has increasingly been focused on photodynamic therapy (PDT) with photosensitizer, i.e., Photofrin (R) [1, 2] . Transbronchial resection using the neodymium yttriumaluminum-garnet (Nd-YAG) laser has become well accepted after the initial reports of its efficacy were published. Transmitted through optical fibers, the Nd-YAG laser provides excellent vaporization, low absorption by hemoglobin, and good tissue penetration 5-10mm from the focal point with highenergy output. Good results were reported in cases of symptomatic endobronchial tumor obstruction treated with the Nd-YAG laser [3] . The [5] . In this paper, we have discussed the effectiveness of PDT and Nd-YAG laser treatments performed at our institution for obstructed lung carcinoma. The procedures also differed in that the laser used in PDT could be inserted safely into the tumor for treatment without perforation or harm to adjacent vessels. With the Nd-YAG laser, however, bronchial wall perforation or massive hemorrhaging resulting from the blood vessel injury sometimes occurred [6] . This study shows that in the bronchial wall, tumor necrosis is not induced as effectively by Nd-YAG laser treatment as it is by PDT. This is true, especially in the smaller bronchi, because of the lesser margin for error with the Nd-YAG laser before entering the vessel. Nd-YAG treatment in distal bronchi is extremely difficult and dangerous. Hemorrhage from pulmonary vessels was one of the major complications of using the Nd-YAG laser, [10] . In these days, second generation photosensitizers for example Npe6 and m-THPC which are able to excite by longer wavelength than Photofrin (R) has been developed [11, 12] 
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